Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis

Posted by Leanne Kodsman on

Pooled Normal Human Serum from Innovative Research was recently used in the following study:

Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis

Yan Li, Fiona Clow, John D. Fraser, Feng Lin
Journal of Molecular Medicine, September 2018

" ... Recombinant SSL7 and SSL7-C5a SSL7 mutant lacking C5 binding activity were overexpressed in Escherichia coli and purified following the protocol described in previous reports [16, 20]. Pooled normal human serum (NHS) as the source of complement was purchased from Innovative Research (Novi, MI)."

Related products available from Innovative Research also include:


Share this post


Related Posts

Plasma ameliorates endothelial dysfunction in burn injury
Sprague Dawley Rat Plasma from Innovative Research was recently used in the following s...
Read the Article

← Older Post Newer Post →